anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

224,641-224,700 of 319,975

filter-aware
33
The slide uses a combination of a biological process diagram and a line chart showing tumor cell reduction over time.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
34
23andMe | Investor Presentation Deck | 39 slides23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
35
The slide uses a process-flow diagram at the bottom to map team expertise to the drug discovery pipeline.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
36
Uses a Venn-like diagram to show genetic overlap between asthma and other conditions (COPD, eczema, neuro-inflammation, urticaria) to drive specific R&D strategies.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
37
Uses a bell curve distribution to illustrate the selection strategy for cases and controls.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
38
The slide uses a table to categorize biological targets by cell type and associated disease indications.23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
39
23andMe | Investor Presentation Deck | 39 slides23andMe | Investor Presentation Deck | 39 slides · 23andMe
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
01
Slide 1
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
02
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
03
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
04
The graphic is a stylized geometric representation of an engine or platform.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
05
The slide uses a split-layout with a thesis statement on the left and key metrics on the right.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
06
Includes logos of partners: Lilly, AbbVie, Regeneron, Novartis, Incyte, Abdera Therapeutics, Empirico, Prelude Therapeutics.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
07
The slide uses a timeline-like bar to indicate the current development stage (IND-enabling) for two specific molecules.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
08
The slide uses a structured table to present key drug development metrics.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
09
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
10
The slide uses a two-column layout to present the value proposition of the platform.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
11
The slide demonstrates a therapeutic window improvement by comparing efficacy (killing) vs safety (cytokine release) across concentration gradients.AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
12
The slide uses a comparative experimental design to show that AbCellera molecules (red) perform similarly or better than a reference molecule (black) in killing MAGE-A4+ cells while maintaining specificity (no activity in knockout cells).AbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
13
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
14
AbCellera | Investor Conference Presentation Deck | 14 slidesAbCellera | Investor Conference Presentation Deck | 14 slides · AbCellera
Conference presentation Investor relations 1 hit
01
Slide 1
The slide uses Python-like code snippets as a design element to represent the company's computational drug discovery platform.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
02
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
03
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
04
The slide uses a flywheel-style circular process to demonstrate the iterative nature of their drug creation platform.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
05
The slide uses a circular diagram to represent the AI-driven feedback loop between wet-lab data generation and model training.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
06
The slide illustrates a process flow from target antigen to AI-designed antibodies.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The slide uses a circular process diagram to link AI design with wet-lab validation.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
08
The slide uses a linear process flow with icons representing the transformation of biological inputs through AI models.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
09
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
10
The right side uses a dot-plot style visualization to represent the economic structure of a partnership, moving from R&D funding to commercial royalties.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
11
The slide uses a Venn diagram to categorize partnerships. The 'Internal Asset Pipeline' section includes a small table/chart showing three programs (ABS-101, ABS-201, ABS-301).Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
12
The slide uses a Gantt-style chart to show the progress of three assets (ABS-101, ABS-201, ABS-301) across development stages.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
13
The slide uses a split-screen approach: biological mechanism on the left, market sizing on the right.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
14
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
15
Uses a before-after framing to show how affinity translates to potency.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
16
The slide uses a before-after structure to demonstrate the superiority of the ABS-101 platform over competitors (RVT-3101, MK-7240).Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
17
The visual shows a 3D protein structure with highlighted binding regions for various antibodies.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
18
The table uses checkmarks and crosses to indicate the presence or absence of specific therapeutic attributes across four different drug programs.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
19
Absci | Investor Conference Presentation Deck | 22 slidesAbsci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
20
Includes logos of partner/talent source institutions and photos of the team and lab facilities.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
21
Includes a dog (Penelope) as 'Chief Morale Officer' as a lighthearted team member entry.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations 1 hit
22
The slide uses a curved timeline with icons to represent milestones and a right-hand column for strategic value propositions.Absci | Investor Conference Presentation Deck | 22 slides · Absci
Conference presentation Investor relations 1 hit
01
Slide 1
a.k.a. Brands | Investor Presentation Deck | 14 slidesa.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Humble Origins1 hit
02
The slide features a lifestyle image on the left and the company logo and mission statement on the right.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Humble Origins1 hit
03
The slide features logos and lifestyle imagery for brands like Culture Kings, Petal & Pup, MNML, and Princess Polly.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Humble Origins1 hit
04
a.k.a. Brands | Investor Presentation Deck | 14 slidesa.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Early Struggles1 hit
05
The slide uses a table-like structure to map strategic pillars to operational outcomes.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Early Struggles1 hit
06
a.k.a. Brands | Investor Presentation Deck | 14 slidesa.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Early StrugglesLoop · Cost Of Inaction1 hit
07
The slide uses a collage of lifestyle photography to establish brand identity alongside key business facts.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
08
The slide serves as a brand introduction or company profile.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
09
The slide uses a collage of lifestyle photography and store imagery to establish brand identity.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
10
The slide serves as a brand profile/context slide for a company called mnml.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
11
The slide uses a before-after framing to track progress against specific corporate goals.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
12
The chart highlights a positive trend in US comps, reaching 2% in Q3 2023.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · The BreakthroughLoop · Cost Of Inaction1 hit
13
The slide uses two line charts to demonstrate financial health improvement.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · The BreakthroughLoop · Quick Win Big Bet1 hit
14
The slide uses a numbered list format to present strategic growth pillars over a background image.a.k.a. Brands | Investor Presentation Deck | 14 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
01
Slide 1
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Setup1 hit
02
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Setup1 hit
03
Alkermes | Investor Conference Presentation Deck | 29 slidesAlkermes | Investor Conference Presentation Deck | 29 slides · Alkermes
Conference presentation Investor relations Beat · Setup1 hit